Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 8 results found. Search for [ Lawsuit In 44 US States ]

Results 1 to 8 of 8
May 23, 2019
Share Market Update:  At closing hour, Indian equity market lost all gains with benchmark indices falling around 1 per cent each to bearish territory. While Sensex ended down by 354 points or 0.91 per cent at 38,756.08, Nifty was down by 106 points or 0.91 per cent down at 11,631.

E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.

New Delhi, May 15, 2019
After Cognizant, IBM India fires 300 employees from services divisionTech behemoth IBM India has reportedly fired nearly 300 employees from its services division as it looks to \"re-invent\" its operations and fulfill the changing demand of the customers. The US-based IT major let these employees go as it focuses on emerging technology like Artificial Intelligence and reduces exposure to traditional services. US pharma scandal: Indian firm Glenmark may face a penalty of up to $873 millio...

May 15, 2019
Share Market Updates: Shedding gains of the trading session Wednesday, benchmark indices closed in the red. Other major indices gave up all intraday gains to turn negative in trade as well.

Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.

Aprajita Sharma
May 14, 2019
The ongoing trade war between the US and China had triggered the recent correction in the market

New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases

Zeba Siddiqui
New Delhi, March 7, 2016
Dinesh Thakur, who exposed dangerous practices in generic drug industry in 2013, is accusing the drug regulators of failing to enforce safety rules in the $15 billion industry.